Welcome to BioMarket Group!

Winning Product Launch Strategies: A case study-based analysis of best practice in pharma

Additional Information

Published Date Jul 3, 2003
Special Offer No
Pages 145
PDF Fact Sheet View Fact Sheet for the report Winning Product Launch Strategies: A case study-based analysis of best practice in pharma in PDF format.
Published on Date No
Format No
Publisher Business Insights
Product Line No
Full Title Winning Product Launch Strategies: A case study-based analysis of best practice in pharma

Availability: In stock

$2,875.00

Quick Overview

A case study-based analysis of best practice in pharma, reveals the most successful product launch strategies that have propelled market leaders to their positions and highlights the critical success factors that can be used as a benchmark for future strategy formulation.
Request free sample pages from Winning Product Launch Strategies: A case study-based analysis of best practice in pharma

Executive Summary

The management report, Winning Product Launch Strategies: A case study-based analysis of best practice in pharma, reveals the most successful product launch strategies that have propelled market leaders to their positions and highlights the critical success factors that can be used as a benchmark for future strategy formulation. The case examples analyzed in this report will help you to minimize the set-up time and costs of experimentation by learning from the industry’s leaders. This report will enable you to determine how to position a new product for launch from immature, through to mature therapeutic markets, generating higher profits and greater market presence.

Request free sample pages from Winning Product Launch Strategies: A case study-based analysis of best practice in pharma

Other selected research from the 'Management' category:


Harnessing Patient Power: Strategies for speeding drug approval, building and retaining market share
This report outlines the developments in pharma-patient group alliances and provides a guide for maximizing their impact across a range of pharma activities: clinical trial recruitment, product launches, CME programs, disease awareness and education initiatives. Learn More


Addressing Pharmas R&D Productivity Crisis: Technological and Strategic Initiatives to Improve Core Drug Discovery Capabilities
External pressures make it difficult to maintain the growth enjoyed by the pharmaceutical industry over the past two decades. Expenditure on R&D is increasing but is not accompanied by corresponding growth in the number of new drugs reaching the market. Companies must fundamentally review R&D business models and exploit new strategies for re-establishing core drug discovery expertise Learn More